Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $313,294 (100.0% shares, 0.0% debt)

Holdings (21)

REPL Replimune Group 26.1%

Value ($000) $81,691 Shares 4,673,380 Est. Cost $17.40 Unrealized -5.6%

NUVB Nuvation Bio 15.8%

Value ($000) $49,401 Shares 15,247,340 Est. Cost $11.18 Unrealized -61.0%

— Imago Biosciences 12.9%

Value ($000) $40,421 Shares 3,018,737 Est. Cost $20.03 Unrealized —

— Morphic Holding 7.0%

Value ($000) $21,934 Shares 1,010,769 Est. Cost $19.82 Unrealized —

— Cincor Pharma 5.8%

Value ($000) $18,203 Shares 966,176 Est. Cost $17.54 Unrealized —

— Alpine Immune Sciences 5.5%

Value ($000) $17,272 Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Kronos Bio 4.4%

Value ($000) $13,899 Shares 3,818,283 Est. Cost $29.87 Unrealized —

ARQT Arcutis Biothereapeutics 4.2%

Value ($000) $13,294 Shares 623,836 Est. Cost $26.87 Unrealized -23.7%

GOSS Gossamer Bio 4.0%

Value ($000) $12,555 Shares 1,500,000 Est. Cost $20.85 Unrealized -62.8%

— Ikena Oncology 3.2%

Value ($000) $9,964 Shares 2,249,123 Est. Cost $28.25 Unrealized —

IMUX Immunic Inc 2.0%

Value ($000) $6,205 Shares 1,788,160 Est. Cost $13.89 Unrealized -53.9%

SANA Sana Biotechnology, Inc. 1.7%

Value ($000) $5,425 Shares 843,750 Est. Cost $32.56 Unrealized -80.4%

— Omega Alpha SPAC 1.6%

Value ($000) $4,935 Shares 501,000 Est. Cost $9.98 Unrealized —

— Theseus Pharmaceuticals 1.3%

Value ($000) $3,934 Shares 711,479 Est. Cost $12.68 Unrealized —

— Paratek Pharmaceuticals 1.2%

Value ($000) $3,804 Shares 1,971,241 Est. Cost $34.18 Unrealized —

— Spruce Biosciences 1.2%

Value ($000) $3,760 Shares 2,161,022 Est. Cost $24.31 Unrealized —

— Syros Pharmaceuticals 0.8%

Value ($000) $2,419 Shares 2,512,705 Est. Cost $8.72 Unrealized —

IMCR Immunocore Holdings 0.6%

Value ($000) $1,923 Shares 51,535 Est. Cost $42.57 Unrealized —

— ESSA Pharma 0.3%

Value ($000) $1,034 Shares 328,196 Est. Cost $3.14 Unrealized —

— Jounce Therapeutics 0.3%

Value ($000) $835 Shares 275,513 Est. Cost $21.99 Unrealized —

— Senti Biosciences, Inc. 0.1%

Value ($000) $386 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	4,673,380	$81,691	26.1%	$17.40	-5.6%	Common Stock	76029N106
NUVB	Nuvation Bio	15,247,340	$49,401	15.8%	$11.18	-61.0%	Common Stock Class A	67080N101
—	Imago Biosciences	3,018,737	$40,421	12.9%	$20.03	—	Common Stock	45250K107
—	Morphic Holding	1,010,769	$21,934	7.0%	$19.82	—	Common Stock	61775R105
—	Cincor Pharma	966,176	$18,203	5.8%	$17.54	—	Common Stock	17240Y109
—	Alpine Immune Sciences	2,029,580	$17,272	5.5%	$9.48	—	Common Stock	02083G100
—	Kronos Bio	3,818,283	$13,899	4.4%	$29.87	—	Common Stock	50107A104
ARQT	Arcutis Biothereapeutics	623,836	$13,294	4.2%	$26.87	-23.7%	Common Stock	03969K108
GOSS	Gossamer Bio	1,500,000	$12,555	4.0%	$20.85	-62.8%	Common Stock	38341P102
—	Ikena Oncology	2,249,123	$9,964	3.2%	$28.25	—	Common Stock	45175G108
IMUX	Immunic Inc	1,788,160	$6,205	2.0%	$13.89	-53.9%	Common Stock	4525EP101
SANA	Sana Biotechnology, Inc.	843,750	$5,425	1.7%	$32.56	-80.4%	Common Stock	799566104
—	Omega Alpha SPAC	501,000	$4,935	1.6%	$9.98	—	Common Stock Class A	G6749V107
—	Theseus Pharmaceuticals	711,479	$3,934	1.3%	$12.68	—	Common Stock	88369M101
—	Paratek Pharmaceuticals	1,971,241	$3,804	1.2%	$34.18	—	Common Stock	699374302
—	Spruce Biosciences	2,161,022	$3,760	1.2%	$24.31	—	Common Stock	85209E109
—	Syros Pharmaceuticals	2,512,705	$2,419	0.8%	$8.72	—	Common Stock	87184Q107
IMCR	Immunocore Holdings	51,535	$1,923	0.6%	$42.57	—	ADS	45258D105
—	ESSA Pharma	328,196	$1,034	0.3%	$3.14	—	Common Stock	29668H708
—	Jounce Therapeutics	275,513	$835	0.3%	$21.99	—	Common Stock	481116101
—	Senti Biosciences, Inc.	195,792	$386	0.1%	$1.97	—	Common Stock	81726A100